CUMBERLAND PHARMACEUTICALS INC — Form 8-K/A
Filed September 11, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 28/100
What the filing says
Cumberland Pharmaceuticals filed an amended 8-K/A on 2026-09-11 (accepting 2026-04-21 shareholder vote matter). The filing covers Item 5.07 (Submission of Matters to a Vote of Security Holders) but the actual vote details, counterparties, dollar amounts, percentages, or share counts are not disclosed in this document index. The specific nature of the shareholder matter and outcomes cannot be determined from the metadata provided.
Why this rating
Amendment to routine disclosure; no material financial terms visible. Company scale $29.4M makes typical shareholder votes routine unless tied to transformational event.
Extracted items
See more from September 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.